Skip to search formSkip to main contentSkip to account menu

Trpm2 protein, rat

Known as: transient receptor potential melastatin 2, rat 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Aim: Imatinib mesylate is a tyrosine kinase inhibitor and is approved as a standard first-line therapy of chronic myeloid… 
2017
2017
ÖZET Amaç: Akciğer kanserli dokularda, iyon kanalı olan transient reseptör potansiyel melastatin (TRPM) grubu TRPM2, 4, 5, 7, 8…